The Future of Biomanufacturing: Key Highlights from INTERPHEX 2026

Welcome to BioPharm International®’s post-INTERPHEX 2026 conference recap. At INTERPHEX this year, two key panel discussions highlighted how biomanufacturing is rapidly evolving—both inside the facility and across the global supply chain.

In one session, experts explored how single-use technologies are becoming smarter and more connected. With the rise of automation and continuous processing, biomanufacturers are moving toward more efficient, flexible operations. But scaling these systems and integrating data-driven control remains a challenge. Panelists emphasized the growing role of real-time monitoring and digital quality tools to help close that gap.

“Those same characteristics and benefits of single use might actually now be concerns for long duration, especially in commercial manufacturing,” said David Chau, PhD, global technical product specialist, Thermo Fisher Scientific, at the show. “Single-use technology, by its definition, the whole point of it was that it was for a limited use. It was for a limited time.”

“What we're really doing as an industry is looking at how far can we push them? Or what can we replace some of these materials of construction [with] that can go the distance?” added Stuart Tindal, EngD, portfolio manager, Intensified Downstream Systems, Sartorious, at the show.

In another discussion, the focus shifted to supply chain resilience. The COVID-19 pandemic exposed critical weaknesses in how essential materials like media and buffers are sourced and delivered. Today, industry leaders are rethinking that model, for example, moving toward distributed manufacturing and on-demand production to reduce risk, cost, and environmental impact.

“Finding technologies and finding innovative supply chain approaches to be able to bridge that gap without sacrificing on the basics and the foundational quality standards, regulatory approaches, not putting the product at risk. That's the key,” said Bryan Poltilove, strategic advisor and independent board director, Bryan Poltilove, at the show.

Conversations such as these point to a future in which biomanufacturing is not only more advanced, but more adaptable, resilient, and sustainable. Thank you for joining BioPharm International in this post-conference recap. For more conference coverage, you can visit www.BioPharmInternational.com. Thanks for watching!